课题基金 / 基金详情

项目摘要

项目成果

CHRISTOPHER C BRODER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The paramyxoviruses, as a group, include many important human and animal pathogens, such as measles virus, the parainfluenza viruses, and the highly pathogenic, emerging, zoonotic henipaviruses: Hendra virus (HeV) and Nipah virus (NiV). HeV and NiV have a uniquely broad host tropism, infecting both animals and humans, causing a systemic and often fatal respiratory and/or neurological disease in at least 12 species across 6 orders of mammals. Both pose significant biothreats to both humans and economically important livestock. Henipaviruses, possess two membrane glycoproteins involved in virus entry, one mediates host cell receptor attachment (G glycoprotein) and the other is a Class I fusion (F) glycoprotein which facilitates fusion between the virion and host cell membranes. The G and F glycoproteins are also the major antigens of the virus-neutralizing antibody response in infected hosts and the targets of several antiviral strategies aimed at blocking virus entry. Conversely, the matrix (M) protein is an essential structural component of the virion and has been shown to play a central role in the morphogenesis and budding of progeny virus. Henipavirus M possess a unique ability to assemble and bud from cells in the absence of other viral proteins. Although extensively explored, many details of both the receptor binding and fusion triggering steps and the assembly and budding of progeny virions remain ill-defined for the henipaviruses and paramyxoviruses in general. Both the entry and exit of virus from the host cell are critical processes which also influence host tropism, and the henipaviruses are new virological systems in which to explore unanswered questions about these aspects of paramyxoviruses and negative-stranded enveloped RNA viruses in general. Studies on henipaviruses will further a detailed understanding of their cell biology and host cell interaction involved in virus entry and egress. Findings from these efforts will provide insight into the mechanisms that foster efficient cross-species transmission and also make them important pathogens, and will aid in the development of new antiviral strategies. Our efforts have focused on the henipavirus F and G glycoproteins, the receptor-binding and fusion steps, and the assembly and budding of virus-like-particles. Using the extensive data and systems we have developed in studying HeV and NiV, together with a new species of henipavirus, our objectives in the continuation of our program will be to further detail stages in the fusion and entry process and the assembly and budding of virus particles. Specifically, we will: 1) Characterize henipavirus matrix driven particle assembly in host cells including those from their bat hosts; 2) Identify and characterize the domains involved in the interaction and fusion-triggering mechanism between the henipavirus F and G glycoproteins; 3) Define and detail the interactions between the host cell ephrin receptors and henipavirus G glycoproteins.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
Recombinant Soluble Henipavirus Glycoprotein Preparation.
重组可溶性亨尼帕病毒糖蛋白制剂。
DOI: 10.1007/978-1-0716-3283-3_3
发表时间: 2023
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Yan,Lianying, Sterling,SpencerL, Fusco,DeborahL, Chan,Yee-Peng, Xu,Kai, Laing,EricD, Broder,ChristopherC]
通讯作者: Broder,ChristopherC
DOI: 10.3201/eid2003.131159
发表时间: 2014-03
期刊: Emerging infectious diseases
影响因子: 11.8
作者: [Middleton D, Pallister J, Klein R, Feng YR, Haining J, Arkinstall R, Frazer L, Huang JA, Edwards N, Wareing M, Elhay M, Hashmi Z, Bingham J, Yamada M, Johnson D, White J, Foord A, Heine HG, Marsh GA, Broder CC, Wang LF]
通讯作者: Wang LF
DOI: 10.1016/j.antiviral.2013.06.012
发表时间: 2013-10
期刊: ANTIVIRAL RESEARCH
影响因子: 7.6
作者: [Broder, Christopher C., Xu, Kai, Nikolov, Dimitar B., Zhu, Zhongyu, Dimitrov, Dimiter S., Middleton, Deborah, Pallister, Jackie, Geisbert, Thomas W., Bossart, Katharine N., Wang, Lin-Fa]
通讯作者: Wang, Lin-Fa
DOI: 10.1126/scitranslmed.3008929
发表时间: 2014-06-25
期刊: Science translational medicine
影响因子: 17.1
作者: [Geisbert TW, Mire CE, Geisbert JB, Chan YP, Agans KN, Feldmann F, Fenton KA, Zhu Z, Dimitrov DS, Scott DP, Bossart KN, Feldmann H, Broder CC]
通讯作者: Broder CC
9
    Project 3 - USUHS
    Core A - Administrative Core
    Project-004
    Advancement of Vaccines and Therapies for Henipaviruses
    海外基金